A 38-year-old woman resident of Ivory Coast died of AIDS, while remaining human immunodeficiency virus (HIV)-seronegative. She had been regularly tested because her husband was HIVseropositive. The subject's lack of specific antibodies was assessed using commercial tests and confirmed by a radioimmunoprecipitation assay of the patient's virus. She was unquestionably HIV-1-infected, with a high plasma virus load, and her virus could be isolated. Molecular analyses indicated this retrovirus was clade A, which is common in Africa, and it was highly homologous to the virus isolated from her husband. The subject's seronegative status was thought to be due to rapid depletion of specific CD4
Human immunodeficiency virus (HIV) primary infection is
pleted cells from a healthy donor. Cells were stimulated using commonly associated with clinical symptoms. Seroconversion protein A (10 mg/mL) for 2 days and cultivated in RPMI medium usually occurs within 2-4 months, which is followed by alterwith 10% fetal calf serum and 10% T cell growth factor (Biotest, ations in the immune system, including the progressive depleDreiseich, Germany). Virus isolations from IC1 and IC2 were tion of CD4 lymphocytes [1] . Serologic screening of HIV infecnever done at the same time to preclude the possibility of crosstion is highly sensitive (as shown in intravenous drug users, contamination.
prostitutes, high-risk homosexuals, and hemophiliacs). HIV an- HIV-infected subjects has been reported in only 3 cases [2] [3] [4] .
PCR-based detection of HIV-1 was done with DNA either diWe analyzed the clinical and laboratory findings of a woman rectly purified from isolated peripheral blood lymphocytes (PBL) resident of the Ivory Coast who died of AIDS but remained or after in vitro amplification of HIV in the presence of PBL from HIV-seronegative, even though she was demonstratively ina healthy donor. DNA was extracted using the QiAamp blood kit fected by clade A HIV-1.
(Qiagen; Chatsworth, CA). Two nested PCR assays were used, one with a target within the pol gene and the other with a target within the env gene. For the pol gene assay, the outer primers
Subjects and Methods
were HPOL 4235 and HPOL 4538; the inner primers were HPOL Subjects. A 38-year-old woman (IC2) was married to a man 4327 and HPOL 4481 [6] . For the env-specific assay, the outer (IC1) known to have been HIV-seropositive since 1987. Both lived primers were 5V3CB (5-GTACAATGTACACATGGAAT-3) in Ivory Coast and reported unprotected sexual intercourse. Table 1 and 3V3CB (5-GTAGAAAAATT-CCCCTCCAC-3), and the summarizes the serologic, virologic, and clinical features of subject inner primers were J5CB (5-TGTTGAATGG-CAGTCTAGCA-IC2.
3) and J3CB (5-TGTGCATTACAATTTCTGGG-3). Thermal HIV isolation in cell culture. HIV isolation was done as decycling conditions were as described by Fransen et al. [6] , except scribed previously [5] using cocultivation of the patient's periphthat the annealing temperature was 55ЊC. Stringent precautions were taken to exclude any contamination with PCR-generated products.
Sequence determination of PCR products. PCR products were NOTE. CMV, cytomegalovirus; CMV-P and -R, CMV-related pneumopathy and -retinitis, respectively; HBV, hepatitis B virus; HSV, herpes simplex virus; IP, interstitial pneumonitis; ND, not determined; Neg, negative; PBL, peripheral blood lymphyocytes; Pos, positive; RT-PCR, reverse transcription-polymerase chain reaction; WL, weight loss. * Samples were tested with different ELISAs that detect antibodies against clade O viruses. † PCR detection of HIV sequences was done as described in text using either DNA directly extracted from subject's PBL or by coculture after in vitro amplification of isolate.
CD8 conjugated to fluorescein isothiocyanate, CD16, or CD38 conjuity, because p24 is occasionally detected in sera from unin- dures, WB analysis of HIV-1-specific antibodies produced by subject IC1 was typically positive, including antibodies diResults rected against gp120 and gp160 (figure 1). In September 1994, subject IC2 developed lung interstitial Lack of HIV-specific humoral response despite immunologic opacity, suggestive of bacillosis, associated with fever and sigand clinical AIDS features. Because subject IC2's husband nificant weight loss, which was rapidly followed by infections was HIV-seropositive, she was regularly tested by commercial typical of AIDS (table 1) . At that time, she was profoundly ELISA and Western blot (WB) assay for HIV-1 and HIV-2 immunodeficient, although her immune status was normal serologic reactivity beginning in 1989. As summarized in table when previously tested in 1992. Complete depletion of CD4 1, no specific HIV antibodies were ever detected in subject lymphocytes was detected in July 1995, associated with expan-IC2. As shown in figure 1, WB analyses of sera obtained during sion of CD8 T cells bearing the CD38 activation marker, which 1991-1995 were negative for all HIV-1 proteins, except p24. is known to be expanded during the AIDS stage [8] . A dramatic Antibodies against p24 were detected beginning in April 1995. This response was not considered specific for HIV seropositivexpansion of NK lymphocytes (48% of CD16 / cells) was de- tected ex vivo, which is much higher than recently reported cipitated. In contrast, sera from subject IC2 did not immunoprecipitate proteins from her own virus, confirming the lack of for AIDS patients (8.0%-17.5% CD16 / cells) [9] . Virologic studies. Early attempts (in August 1991) to iso-HIV-specific humoral response. The detection of p24 antigenemia in June 1995 suggested late HIV from subjects IC1 and IC2 were unsuccessful. However, no depletion of CD8 T cells was done at that time, dethat subject IC2 was infected by HIV despite negative serologic results. Indeed, as reported above, HIV-1 was isolated at that creasing the sensitivity of the isolation procedure. HIV-1 was isolated from IC1 in February 1993, but no attempt was made time from blood samples, and p24 antigenemia follow-up until the subject's death indicated a very high virus load beginning for IC2 at that time, since she was considered uninfected because of her HIV seronegativity. HIV-1 was successfully isoin August (table 1) . The plasma virus load was determined using two different commercial assays-the Monitor HIV RTlated from both PBMC and plasma from subject IC2 on 5 July 1995 and reisolated on 24 July 1995. The presence of HIV-PCR assay from Roche and the Quantiplex HIV bDNA hybridization assay from Chiron. It is of interest that the results with specific genetic sequences in DNA purified from the PBMC isolated from IC2 was evaluated by PCR. We obtained a spethese 2 tests were always discordant (table 1) . These discrepancies were confirmed on samples obtained on 21 August and cific PCR amplification on 11 July 1995 using consensus primers within the pol gene [6] . Two weeks later, a similar PCR 19 September: The plasma virus load determined by the bDNA assay was higher than the upper limit of quantification. These experiment was negative, although HIV was isolated by coculture.
same discrepancies were observed with plasma samples from subject IC1 (3 November 1995 sample: 26,600 and 0 genome The virus from IC2 was metabolically labeled in vitro and tested for reactivity against antibodies in sera from IC1, IC2, equivalents/mL with bDNA and RT-PCR, respectively; 19 January 1996 sample: 110,900 and 129 genome equivalents/mL and control donors. The results clearly indicate that the virus isolate from IC2 was recognized by antibodies from IC1 and with bDNA and RT-PCR, respectively). Molecular characterization of virus isolates from subjects from another HIV-positive person (figure 1B). In particular, the HIV-1 gp160 and p25 antigens were strongly immunopre-IC1 and IC2. The PCR products obtained either directly from freshly isolated PBMC or from cells infected with the viruses Because subject IC2 was infected with a clade A virus, which is prevalent in Africa, the present study raises questions about isolated in vitro from blood samples from IC1 and IC2 were cloned, and their nucleotide sequences determined. Virus isothe sensitivity of the molecular tests designed to measure plasma virus load. Although there is usually good correlation lated from IC1 and IC2 within the V3-encoding region of the gp120 at the nucleotide level was 95% identical. When the between results obtained by bDNA and RT-PCR, the clade A viruses from the 2 subjects in this study were poorly recognized sequences from IC1 and IC2 isolates were compared with consensus sequence of clade A viruses, the homology was 90% by a commercial PCR kit but correctly detected by bDNA. Similarly, a failure to amplify an HIV-1 variant from clade G and 89%, respectively. Comparison with consensus sequences from other clades (B-H and O) showed a lower level of identity [14] and HIV-1-positive samples collected in Ivory Coast [11] has been reported. Clearly, more studies are needed to evaluate (61%-85%). The identity within the same region among viruses isolated from IC1 and IC2 at the amino acid level was the respective sensitivity of these quantitative assays for patients infected with viruses of African origin. §86%. In addition to this high homology, the V3 regions deduced from all determined sequences showed an unusual
In conclusion, the immunologic and virologic results of the subjects described strongly suggest that the lack of HIV-speinsertion of the tripeptide GPG at the amino side of the loop apex. When considered together, these results indicate that isocific humoral response in subject IC2 was host related rather than related to a specific HIV strain. We believe cases such as lates from IC1 and IC2 are clade A, which is dominant in the Ivory Coast [10] , and argue for HIV transmission from subject this are probably rare, but not exceptional. Regular sex partners of HIV-seropositive persons and of intravenous drug users IC1 to his wife, IC2.
should be followed regularly by both antibody testing (WB and ELISA) and immunologic parameters (absolute CD4 lymphocyte numbers and CD4:CD8 ratio). When clinical or bioDiscussion logic data suggest an HIV infection, direct detection of the virus is recommended. Very few cases of clinical AIDS in HIV-infected but seronegative persons have been reported [2] [3] [4] . In the first two studies, the infecting virus was not characterized, the source Identification and treatment of early infection due to human sion by Ç1 week [8] . The use of techniques to detect viral p24 antigen and RNA in serum also decreases the time between immunodeficiency virus type 1 (HIV-1) has been advocated as a means of reducing viral replication and favorably altering establishment and diagnosis of infection with HIV-1 [9] [10] [11] . We used assays to identify persons with early HIV infection disease progression [1, 2] . As a significant number of persons with primary infection are asymptomatic [3] , it has been sugand sought to determine whether symptomatic primary infection was associated with clinical progression. gested that symptomatic incident HIV-1 infection is associated with more rapid immunologic deterioration and clinical progression [4] [5] [6] [7] . Methods The ''seronegative'' phase of primary infection generally lasts between 2 and 6 weeks [3] . Recently, an EIA capable of The participants included in this analysis were the 267 men with incident infection occurring within an interval of õ7 months (median, 6; range, 4-7) between the last seronegative and first seropositive visit identified using first-generation EIAs. Serum obtained at the last ''seronegative'' visit was retested to determine the preva- interval. Questions relevant to symptoms persisting for 2 weeks
